Amlodipine Besylate is owned by Synthon Pharms.
Amlodipine Besylate contains Amlodipine Besylate.
Amlodipine Besylate has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Amlodipine Besylate are:
Amlodipine Besylate was authorised for market use on 27 September, 2007.
Amlodipine Besylate is available in tablet, orally disintegrating;oral dosage forms.
The generics of Amlodipine Besylate are possible to be released after 20 November, 2022.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.|
|US6828339||SYNTHON PHARMS||Amlodipine salt forms and processes for preparing them|| |
(2 months ago)
Market Authorisation Date: 27 September, 2007
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic